GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amgen Inc (NAS:AMGN) » Definitions » 3-Year Dividend Growth Rate

Amgen (AMGN) 3-Year Dividend Growth Rate : 10.00% (As of Sep. 2024)


View and export this data going back to 1983. Start your Free Trial

What is Amgen 3-Year Dividend Growth Rate?

Amgen's Dividends per Share for the three months ended in Sep. 2024 was $2.25.

The historical rank and industry rank for Amgen's 3-Year Dividend Growth Rate or its related term are showing as below:

AMGN' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 10   Med: 15.95   Max: 63.3
Current: 10

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Amgen was 63.30% per year. The lowest was 10.00% per year. And the median was 15.95% per year.

AMGN's 3-Year Dividend Growth Rate is ranked worse than
54.55% of 308 companies
in the Drug Manufacturers industry
Industry Median: 11.45 vs AMGN: 10.00

During the past 12 months, Amgen's average Dividends Per Share Growth Rate was 7.60% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 10.00% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 10.10% per year. During the past 10 years, the average Dividends Per Share Growth Rate was 15.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Amgen's Dividend Payout Ratio for the three months ended in Sep. 2024 was 0.40. As of today, Amgen's Dividend Yield % is 2.74%.

Warning Sign:

Amgen Inc stock dividend yield is close to 3-year low.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Amgen's 3-Year Dividend Growth Rate

For the Drug Manufacturers - General subindustry, Amgen's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amgen's 3-Year Dividend Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amgen's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Amgen's 3-Year Dividend Growth Rate falls into.



Amgen 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Amgen  (NAS:AMGN) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Amgen's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2024 )/ EPS without NRI (Q: Sep. 2024 )
=2.25/ 5.58
=0.40

During the past 13 years, the highest Dividend Payout Ratio of Amgen was 0.47. The lowest was 0.28. And the median was 0.38.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Amgen Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 2.2500002024-08-162024-08-162024-09-06Cash DividendquarterlyUSD:USD 1.000000
USD 2.2500002024-05-162024-05-172024-06-07Cash DividendquarterlyUSD:USD 1.000000
USD 2.2500002024-02-152024-02-162024-03-07Cash DividendquarterlyUSD:USD 1.000000
USD 2.1300002023-11-162023-11-172023-12-08Cash DividendquarterlyUSD:USD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

Amgen's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=8.88/320.27
=2.77 %

Current Share Price is $320.27.
Amgen's Dividends per Share for the trailing twelve months (TTM) ended in Today is $8.88.

During the past 13 years, the highest Dividend Yield of Amgen was 3.72%. The lowest was 1.35%. And the median was 2.65%.

Warning Sign:

Amgen Inc stock dividend yield is close to 3-year low.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amgen 3-Year Dividend Growth Rate Related Terms>


Amgen Business Description

Industry
Address
One Amgen Center Drive, Thousand Oaks, CA, USA, 91320-1799
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
Executives
Nancy A. Grygiel officer: SVP & CCO ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320
Jonathan P Graham officer: SVP, Gen. Counsel & Secy. 2099 PENNSYLVANIA AVENUE, NW, 12TH FLOOR, WASHINGTON DC 20006
Matthew C. Busch officer: VP, Finance & CAO ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320
Murdo Gordon officer: EVP Global Commercial Ops C/O BRISTOL-MYERS SQUIBB COMPANY, 345 PARK AVE, NEW YORK NY 10154
Rachna Khosla officer: SVP, Business Development ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320
R Sanders Williams director DUKE UNIVERSITY SCHOOL OF MEDICINE, TRENT DRIVE, DURHAM NC 27706
Robert Eckert director MATTEL, INC., 333 CONTINENTAL BLVD, M1-1518, EL SEGUNDO CA 90245
Michael V Drake director ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320
Derek Miller officer: SVP, Human Resources ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320
Omar Ishrak director 710 MEDTRONIC PKWY, MS LC300, MINNEAPOLIS MN 55432
Ronald D Sugar director 10877 WILSHIRE BLVD., SUITE 1650, LOS ANGELES CA 900274
Linda H. Louie officer: VP, Finance & CAO ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320
Amy E Miles director
David Piacquad officer: SVP, Business Development ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320-1799
Peter H. Griffith officer: EVP & CFO ONE AMGEN CENTER DRIVE, THOUSAND OAKS CA 91320